Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

  1. Danese, E.
  2. Raimondi, S.
  3. Montagnana, M.
  4. Tagetti, A.
  5. Langaee, T.
  6. Borgiani, P.
  7. Ciccacci, C.
  8. Carcas, A.J.
  9. Borobia, A.M.
  10. Tong, H.Y.
  11. Dávila-Fajardo, C.
  12. Rodrigues Botton, M.
  13. Bourgeois, S.
  14. Deloukas, P.
  15. Caldwell, M.D.
  16. Burmester, J.K.
  17. Berg, R.L.
  18. Cavallari, L.H.
  19. Drozda, K.
  20. Huang, M.
  21. Zhao, L.-Z.
  22. Cen, H.-J.
  23. Gonzalez-Conejero, R.
  24. Roldan, V.
  25. Nakamura, Y.
  26. Mushiroda, T.
  27. Gong, I.Y.
  28. Kim, R.B.
  29. Hirai, K.
  30. Itoh, K.
  31. Isaza, C.
  32. Beltrán, L.
  33. Jiménez-Varo, E.
  34. Cañadas-Garre, M.
  35. Giontella, A.
  36. Kringen, M.K.
  37. Haug, K.B.F.
  38. Gwak, H.S.
  39. Lee, K.E.
  40. Minuz, P.
  41. Lee, M.T.M.
  42. Lubitz, S.A.
  43. Scott, S.
  44. Mazzaccara, C.
  45. Sacchetti, L.
  46. Genç, E.
  47. Özer, M.
  48. Pathare, A.
  49. Krishnamoorthy, R.
  50. Paldi, A.
  51. Siguret, V.
  52. Loriot, M.-A.
  53. Kutala, V.K.
  54. Suarez-Kurtz, G.
  55. Perini, J.
  56. Denny, J.C.
  57. Ramirez, A.H.
  58. Mittal, B.
  59. Rathore, S.S.
  60. Sagreiya, H.
  61. Altman, R.
  62. Shahin, M.H.A.
  63. Khalifa, S.I.
  64. Limdi, N.A.
  65. Rivers, C.
  66. Shendre, A.
  67. Dillon, C.
  68. Suriapranata, I.M.
  69. Zhou, H.-H.
  70. Tan, S.-L.
  71. Tatarunas, V.
  72. Lesauskaite, V.
  73. Zhang, Y.
  74. Maitland-van der Zee, A.H.
  75. Verhoef, T.I.
  76. de Boer, A.
  77. Taljaard, M.
  78. Zambon, C.F.
  79. Pengo, V.
  80. Zhang, J.E.
  81. Pirmohamed, M.
  82. Johnson, J.A.
  83. Fava, C.
  84. Erakutsi egile guztiak +
Aldizkaria:
Clinical Pharmacology and Therapeutics

ISSN: 1532-6535 0009-9236

Argitalpen urtea: 2019

Alea: 105

Zenbakia: 6

Orrialdeak: 1477-1491

Mota: Artikulua

DOI: 10.1002/CPT.1323 GOOGLE SCHOLAR